Table 3.
Vaccine | Target population | Age (yrs) | N | Primary endpoint | Sponsor | Country | Clinical trial identifier |
---|---|---|---|---|---|---|---|
BCG | Healthy HCWs in ED, ICU, isolation ward | ≥18 | 900 | Incidence of COVID-19 cases | Ain Shams University | Egypt | NCT04350931 |
BCG | COVID-19 patients TST+ and TST- Case-Control | 12–80 | 100 | Pneumonia severity, need for ICU admission in TST+ and TST- patients | Assiut University | Egypt | NCT04347876 |
BCG | COVID-19 patients | ≥18 | 1,000 | COVID-19 progression, elimination, seroconversion | University of Campinas | Brazil | NCT04369794 |
BCG | COVID+ patients or COVID- patients who have been in contact with COVID-19 | 18–80 | 400 | Differences in epidemiological characteristics | Direction des Soins de Santé de Base | Tunisia | NCT04384614 |
BCG | Healthy HCWs treating COVID-19 patients | 18–100 | 1,500 | HCW absenteeism | Bandim Health Project | Denmark | NCT04373291 |
BCG | Healthcare workers | ≥18 | 1,500 | HCW absenteeism | UMC Utrecht | Netherlands | NCT04328441 |
BCG | Healthy HCWs in contact with COVID-19 patients | ≥18 | 500 | Incidence hospitalized due to COVID-19 | TASK Applied Science | South Africa | NCT04379336 |
BCG | Healthy HCWs treating COVID-19 patients | 18–65 | 1,000 | Incidence of COVID-19 cases | University of Antioquia | Columbia | NCT04362124 |
BCG | Healthy HCWs (BRACE Trial) | ≥18 | 10,078 | COVID-19 disease incidence and severe COVID-19 incidence | Murdoch Children's Research Unit | Australia | NCT04327206 |
BCG | Healthy HCWs in direct contact with COVID-19 patients (≥25 h/wk) | 18–75 | 1,800 | Incidence of COVID-19 infection | Texas A&M University | USA | NCT04348370 |
BCG | Healthy HCWs in contact with COVID-19 patients | ≥18 | 1,120 | Incidence of COVID-19 infection | Assistance Publique—Hôpitaux de Paris | France | NCT04384549 |
MMR | Healthy HCWs during COVID-19 outbreak | 18–50 | 200 | Incidence of COVID-19 disease | Kasr El Aini Hospital | Egypt | NCT04357028 |
BCG, bacillus Calmette-Guérin vaccine; MMR, measles-mumps-rubella vaccine; HCW, healthcare worker; TST, tuberculin skin test.